Status:
COMPLETED
Study Evaluating Sirolimus in the Treatment of Kidney Transplant
Lead Sponsor:
Wyeth is now a wholly owned subsidiary of Pfizer
Conditions:
Kidney Failure
Kidney Diseases
Eligibility:
All Genders
Phase:
PHASE4
Brief Summary
The aim of this study is to test whether withdrawal of calcineurin inhibitors, followed by treatment with sirolimus, may improve renal function in renal transplant recipients with chronic allograft ne...
Eligibility Criteria
Inclusion
- Renal transplantation
- Biopsy-confirmed chronic rejection
- Treatment with mofetil mycophenolate among cyclosporine or tacrolimus
Exclusion
- Transplant of any organ other than the kidney
- Current important infection
- Acute rejection within 12 weeks prior to inclusion
Key Trial Info
Start Date :
August 1 2006
Trial Type :
INTERVENTIONAL
End Date :
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT00282217
Start Date
August 1 2006
Last Update
March 22 2007
Active Locations (13)
Enter a location and click search to find clinical trials sorted by distance.
1
A Coruña, Spain, 15006
2
Albacete, Spain, 2006
3
Barcelona, Spain, 8035
4
Cadiz, Spain, 11009